Literature DB >> 26548414

Antihyperalgesic effect of tetrodotoxin in rat models of persistent muscle pain.

P Alvarez1, J D Levine2.   

Abstract

Persistent muscle pain is a common and disabling symptom for which available treatments have limited efficacy. Since tetrodotoxin (TTX) displays a marked antinociceptive effect in models of persistent cutaneous pain, we tested its local antinociceptive effect in rat models of muscle pain induced by inflammation, ergonomic injury and chemotherapy-induced neuropathy. While local injection of TTX (0.03-1 μg) into the gastrocnemius muscle did not affect the mechanical nociceptive threshold in naïve rats, exposure to the inflammogen carrageenan produced a marked muscle mechanical hyperalgesia, which was dose-dependently inhibited by TTX. This antihyperalgesic effect was still significant at 24h. TTX also displayed a robust antinociceptive effect on eccentric exercise-induced mechanical hyperalgesia in the gastrocnemius muscle, a model of ergonomic pain. Finally, TTX produced a small but significant inhibition of neuropathic muscle pain induced by systemic administration of the cancer chemotherapeutic agent oxaliplatin. These results indicate that TTX-sensitive sodium currents in nociceptors play a central role in diverse states of skeletal muscle nociceptive sensitization, supporting the suggestion that therapeutic interventions based on TTX may prove useful in the treatment of muscle pain.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  clinical trials; delayed-onset muscle soreness; inflammation; mechanical hyperalgesia; neuropathic muscle pain; voltage-dependent sodium channels

Mesh:

Substances:

Year:  2015        PMID: 26548414      PMCID: PMC4679288          DOI: 10.1016/j.neuroscience.2015.10.059

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  58 in total

1.  Different roles of peripheral mitogen-activated protein kinases in carrageenan-induced arthritic pain and arthritis in rats.

Authors:  Hongxiu Han; Kyu-Sang Lee; Weifang Rong; Guohua Zhang
Journal:  Anesth Analg       Date:  2012-07-19       Impact factor: 5.108

2.  Low dose of tetrodotoxin reduces neuropathic pain behaviors in an animal model.

Authors:  Y S Lyu; S K Park; K Chung; J M Chung
Journal:  Brain Res       Date:  2000-07-14       Impact factor: 3.252

3.  Muscle pain in models of chemotherapy-induced and alcohol-induced peripheral neuropathy.

Authors:  Pedro Alvarez; Luiz F Ferrari; Jon D Levine
Journal:  Ann Neurol       Date:  2011-07       Impact factor: 10.422

4.  Role of interleukin-6 in chronic muscle hyperalgesic priming.

Authors:  O A Dina; P G Green; J D Levine
Journal:  Neuroscience       Date:  2008-01-12       Impact factor: 3.590

5.  Changes in the expression of NaV1.7, NaV1.8 and NaV1.9 in a distinct population of dorsal root ganglia innervating the rat knee joint in a model of chronic inflammatory joint pain.

Authors:  Iain T Strickland; Jo C Martindale; Peter L Woodhams; Alison J Reeve; Iain P Chessell; Daniel S McQueen
Journal:  Eur J Pain       Date:  2007-10-18       Impact factor: 3.931

6.  An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways.

Authors:  Jennifer R Deuis; Katharina Zimmermann; Andrej A Romanovsky; Lourival D Possani; Peter J Cabot; Richard J Lewis; Irina Vetter
Journal:  Pain       Date:  2013-05-24       Impact factor: 6.961

7.  Time course of capillary structure changes in rat skeletal muscle following strenuous eccentric exercise.

Authors:  Y Kano; K Sampei; H Matsudo
Journal:  Acta Physiol Scand       Date:  2004-03

8.  Differential anti-neuropathic pain effects of tetrodotoxin in sciatic nerve- versus infraorbital nerve-ligated rats--behavioral, pharmacological and immunohistochemical investigations.

Authors:  Valérie Kayser; Florent Viguier; Myrto Ioannidi; Jean-François Bernard; Alban Latrémolière; Benoît Michot; José-Miguel Vela; Helmut Buschmann; Michel Hamon; Sylvie Bourgoin
Journal:  Neuropharmacology       Date:  2009-09-09       Impact factor: 5.250

Review 9.  Tetrodotoxin: chemistry, toxicity, source, distribution and detection.

Authors:  Vaishali Bane; Mary Lehane; Madhurima Dikshit; Alan O'Riordan; Ambrose Furey
Journal:  Toxins (Basel)       Date:  2014-02-21       Impact factor: 4.546

10.  Pain without nociceptors? Nav1.7-independent pain mechanisms.

Authors:  Michael S Minett; Sarah Falk; Sonia Santana-Varela; Yury D Bogdanov; Mohammed A Nassar; Anne-Marie Heegaard; John N Wood
Journal:  Cell Rep       Date:  2014-01-16       Impact factor: 9.423

View more
  12 in total

Review 1.  Sodium channels and pain: from toxins to therapies.

Authors:  Fernanda C Cardoso; Richard J Lewis
Journal:  Br J Pharmacol       Date:  2017-09-02       Impact factor: 8.739

2.  Nociceptor Overexpression of NaV1.7 Contributes to Chronic Muscle Pain Induced by Early-Life Stress.

Authors:  Pedro Alvarez; Oliver Bogen; Paul G Green; Jon D Levine
Journal:  J Pain       Date:  2021-02-24       Impact factor: 5.820

Review 3.  Current Trends and New Challenges in Marine Phycotoxins.

Authors:  Maria Carmen Louzao; Natalia Vilariño; Carmen Vale; Celia Costas; Alejandro Cao; Sandra Raposo-Garcia; Mercedes R Vieytes; Luis M Botana
Journal:  Mar Drugs       Date:  2022-03-08       Impact factor: 5.118

4.  Effects of Tetrodotoxin in Mouse Models of Visceral Pain.

Authors:  Rafael González-Cano; Miguel Ángel Tejada; Antonia Artacho-Cordón; Francisco Rafael Nieto; José Manuel Entrena; John N Wood; Cruz Miguel Cendán
Journal:  Mar Drugs       Date:  2017-06-21       Impact factor: 5.118

5.  Effect of Tetrodotoxin Pellets in a Rat Model of Postherpetic Neuralgia.

Authors:  Bihong Hong; Jipeng Sun; Hongzhi Zheng; Qingqing Le; Changsen Wang; Kaikai Bai; Jianlin He; Huanghuang He; Yanming Dong
Journal:  Mar Drugs       Date:  2018-06-05       Impact factor: 5.118

6.  Nav1.7 via Promotion of ERK in the Trigeminal Ganglion Plays an Important Role in the Induction of Pulpitis Inflammatory Pain.

Authors:  Shukai Sun; Jiangxing Sun; Wenkai Jiang; Wei Wang; Longxing Ni
Journal:  Biomed Res Int       Date:  2019-03-28       Impact factor: 3.411

Review 7.  The Role of Toxins in the Pursuit for Novel Analgesics.

Authors:  Yossi Maatuf; Matan Geron; Avi Priel
Journal:  Toxins (Basel)       Date:  2019-02-23       Impact factor: 4.546

8.  Safety, Tolerability, Pharmacokinetics, and Concentration-QTc Analysis of Tetrodotoxin: A Randomized, Dose Escalation Study in Healthy Adults.

Authors:  Mojgan Kavoosi; Terry E O'Reilly; Mehran Kavoosi; Peng Chai; Caroline Engel; Walter Korz; Christopher C Gallen; Robert M Lester
Journal:  Toxins (Basel)       Date:  2020-08-09       Impact factor: 4.546

Review 9.  An Updated Review of Tetrodotoxin and Its Peculiarities.

Authors:  Panagiota Katikou; Cengiz Gokbulut; Ali Rıza Kosker; Mònica Campàs; Fatih Ozogul
Journal:  Mar Drugs       Date:  2022-01-03       Impact factor: 5.118

Review 10.  Tetrodotoxin, a Potential Drug for Neuropathic and Cancer Pain Relief?

Authors:  Rafael González-Cano; M Carmen Ruiz-Cantero; Miriam Santos-Caballero; Carlos Gómez-Navas; Miguel Á Tejada; Francisco R Nieto
Journal:  Toxins (Basel)       Date:  2021-07-12       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.